Modalis Therapeutics Corporation Environmental Analytics
Environmental and financial analysis dashboard for Modalis Therapeutics Corporation. Industry: PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES
Company Overview for Modalis Therapeutics Corporation
Highlights
Showing data for FY2022
Operational Environmental Cost
$0.00m
Operational Environmental Cost Intensity
1.38%
Total Environmental Cost
N/A
Total Environmental Cost Intensity
N/A
ΔOperational Environmental Cost (2020-2022)
$-0.02m
Decoupling Rate (2020-2022)
-28%
Adjusted EBITDA
$-20m
Adjusted EBITDA Margin
-6,368%
Environmental cost statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| OPERATIONAL SOCIAL COST OF CARBON | ||||
| -99.61% | 3701.27% | N/A | ||
| 0.29% | 0.37% | 0.45% | N/A | |
| -99.58% | 3607.12% | N/A | ||
| 0.56% | 0.78% | 0.93% | N/A | |
| $0m | $0m | $0m | N/A | |
| -99.59% | 3637.39% | N/A | ||
| 0.84% | 1.15% | 1.38% | N/A | |
| INDIRECT SOCIAL COST OF CARBON | ||||
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. Scope 2: Social Cost of Carbon is calculated using market-based emissions data. | ||||
Environmental cost bridge
Showing data for FY2022
Integrated financial analysis
Highlights
Showing data for FY2022
Adjusted EBITDA Margin
-6,368%
Adjusted EBIT Margin
-6,674%
EV / Adjusted EBITDA
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
EV / Adjusted EBIT
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
Integrated income statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| INCOME STATEMENT | ||||
$3m | $0m | $0m | $0m | |
| -99.70% | 3000.00% | -100.00% | ||
$7m | $6m | $20m | N/A | |
| 211.68% | 60687.00% | 6466.75% | 0.00% | |
$-4m | $-6m | $-20m | N/A | |
| -111.68% | -60587.00% | -6366.75% | 0.00% | |
$-4m | $-7m | $-21m | N/A | |
| -128.52% | -67666.09% | -6672.12% | 0.00% | |
| ENVIRONMENTAL COST DATA | ||||
$0m | $0m | $0m | N/A | |
| 0.84% | 1.15% | 1.38% | 0.00% | |
| FINANCIAL DATA ADJUSTED FOR OPERATIONAL ENVIRONMENTAL COST | ||||
$-4m | $-6m | $-20m | N/A | |
| -112.53% | -60588.15% | -6368.13% | 0.00% | |
$-4m | $-7m | $-21m | N/A | |
| -129.37% | -67667.24% | -6673.50% | 0.00% | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. | ||||
Environmental EBITDA bridge
Showing data for FY2022
Industry benchmark
RESEARCH AND EXPERIMENTAL DEVELOPMENT ON NATURAL SCIENCES AND ENGINEERING
Scope 1 (% of Sales)
0.45%
Scope 2 (% of Sales)
0.93%
Operational Environmental Cost Intensity
1.38%
Scope 3 (% of Sales)
N/A
Total Environmental Cost Intensity
N/A
Selected peer group
Showing data for FY2022
NAME | COUNTRY | OPERATIONAL ENV. COST | OPERATIONAL ENV. COST INTENSITY |
|---|---|---|---|
Modalis Therapeutics Corporation | N/A | $0m | 1.38% |
Loading similar companies data...
Industry distribution
Showing data for FY2022
Note: Outliers are calculated using the 1.5 * IQR method, where values outside Q1 - 1.5 * IQR and Q3 + 1.5 * IQR are considered outliers.
Estimated Social Cost of Carbon Scope 3 breakdown
Percentage breakdown of Social Cost of Carbon Scope 3 into various categories
Showing data for FY2022
SCOPE 3 CATEGORY | Company (USD) | Company % | Industry Avg (USD) | Industry Avg % |
|---|---|---|---|---|
Purchased goods (1 & 2) | $0m | 22.01% | N/A | N/A |
Energy-related activities (3) | $0m | 1.15% | N/A | N/A |
Upstream transportation (4) | $0m | 0.07% | N/A | N/A |
Waste (5) | $0m | 0.30% | N/A | N/A |
Business travel (6) | $0m | 0.35% | N/A | N/A |
Commuting (7) | $0m | 2.74% | N/A | N/A |
Upstream leased assets (8) | N/A | N/A | N/A | N/A |
Downstream transportation (9) | $0m | 0.33% | N/A | N/A |
Processing of products (10) | N/A | N/A | N/A | N/A |
Use of products (11) | $0m | 72.34% | N/A | N/A |
Final treatment of products (12) | $0m | 0.71% | N/A | N/A |
Downstream leased assets (13) | N/A | N/A | N/A | N/A |
Franchises (14) | N/A | N/A | N/A | N/A |
Investments (15) | N/A | N/A | N/A | N/A |
Total | $0m | 100.00% | $0m | 100.00% |
Scope 3 breakdown visualization
Showing data for FY2022